The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Ocular Preparations: The Formulation Approach
Abstract
The main aim of pharmacotherapeutics is the attainment of an effective drug concentration at the intended site of action for a sufficient period of time to elicit the response. A major problem being faced in ocular therapeutics is the attainment of an optimal concentration at the site of action. Poor bioavailability of drugs from ocular dosage forms is mainly due to the tear production, non-productive absorption, transient residence time, and impermeability of corneal epithelium. This article reviews: (1) the barriers that decrease the bioavailability of an ophthalmic drug; (2) the objectives to be considered in producing optimal formulations; and (3) the approaches being used to improve the corneal penetration of a drug molecule and delay its elimination from the eye. The focus of this review is on the recent developments in topical ocular drug delivery systems, the rationale for their use, their drug release mechanism, and the characteristic advantages and limitations of each system. In addition, the review attempts to give various analytical procedures including the animal models and other models required for bioavailability and pharmacokinetic studies. The latter can aid in the design and predictive evaluation of newer delivery systems. The dosage forms are divided into the ones which affect the precorneal parameters, and those that provide a controlled and continuous delivery to the pre- and intraocular tissues. The systems discussed include: (a) the commonly used dosage forms such as gels, viscosity imparting agents, ointments, and aqueous suspensions; (b) the newer concept of penetration enhancers, phase transition systems, use of cyclodextrins to increase solubility of various drugs, vesicular systems, and chemical delivery systems such as the prodrugs; (c) the developed and under-development controlled/continuous drug delivery systems including ocular inserts, collagen shields, ocular films, disposable contact lenses, and other new ophthalmic drug delivery systems; and (d) the newer trends directed towards a combination of drug delivery technologies for improving the therapeutic response of a non-efficacious drug. The fruitful resolution of the above-mentioned technological suggestions can result in a superior dosage form for both topical and intraocular ophthalmic application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
Lehr, C.-M., Bouwstra, J. A., Schacht, E. H., & Junginger, H. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90353-4 · Cited by 1,035
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
In vitro evaluation of the mucoadhesive properties of chitosan microspheres
He, P., Davis, S. S., & Illum, L. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00027-1 · Cited by 667
Frömming, K.-H., & Szejtli, J. (1994) · Topics in Inclusion Science · doi:10.1007/978-94-015-8277-3 · Cited by 658
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 627
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
LEE, V. H. L., & ROBINSON, J. R. (1986) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1986.2.67 · Cited by 503
An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery
Smart, J. D., Kellaway, I. W., & Worthington, H. E. C. (1984) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1984.tb04377.x · Cited by 467
Ch'Ng, H. S., Park, H., Kelly, P., & Robinson, J. R. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740407 · Cited by 443
Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion
Park, K., & Robinson, J. R. (1984) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(84)90154-6 · Cited by 420
Bioadhesive drug delivery systems
Nielsen, L. S., Schubert, L., & Hansen, J. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10004-5 · Cited by 403
Microspheres and nanoparticles used in ocular delivery systems
Zimmer, A., & Kreuter, J. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00017-2 · Cited by 336
Rheological evaluation of poloxamer as an in situ gel for ophthalmic use
Edsman, K., Carlfors, J., & Petersson, R. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)00075-4 · Cited by 331
Cohen, S., Lobel, E., Trevgoda, A., & Peled, Y. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01523-4 · Cited by 296
Citi, S. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.1.169 · Cited by 275
Rozier, A., Mazuel, C., Grove, J., & Plazonnet, B. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90305-0 · Cited by 266
Olsen, T. W., Edelhauser, H. F., Lim, J. I., & Geroski, D. H. (1995) · PubMed · Cited by 230
Sanborn, G. E. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140044023 · Cited by 230
Bioadhesion of hydrated chitosans: An in vitro and in vivo study
Henriksen, I. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04776-x · Cited by 226
Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits
Miller, S. C., & Donovan, M. D. (1982) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(82)90114-4 · Cited by 210
Rheological evaluation of Gelrite® in situ gels for ophthalmic use
Carlfors, J., Edsman, K., Petersson, R., & Jörnving, K. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)00074-2 · Cited by 209
Physicochemical Determinants of Drug Diffusion Across the Conjunctiva, Sclera, and Cornea
Ahmed, I., Gokhale, R. D., Shah, M. V., & Patton, T. F. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600760802 · Cited by 195
Mechanisms of absorption enhancement and tight junction regulation
Hochman, J., & Artursson, P. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90072-8 · Cited by 186
Journal of Pharmaceutical Sciences
(2006) · Journal of Pharmaceutical Sciences · doi:10.1002/(issn)1520-6017 · Cited by 182
Ocular inserts for topical delivery
Saettone, M. F., & Salminen, L. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00014-x · Cited by 181
Liposomes in topical drug delivery.
Schaeffer, H. E., & Krohn, D. L. (1982) · PubMed · Cited by 170
Bioadhesive Microspheres for Ophthalmic Administration of Acyclovir
Genta, I., Conti, B., Perugini, P., Pavanetto, F., Spadaro, A., & Puglisi, G. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06103.x · Cited by 162
Biopharmaceutics of Ocular Drug Delivery
Edman, P. (2019) · CRC Press eBooks · doi:10.1201/9780429284755 · Cited by 160
Treatment of diseases of the eye with mucoadhesive delivery systems
Greaves, J. L., & WILSON, C. G. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90016-w · Cited by 153
Saettone, M. F., Chetoni, P., Torracca, M. T., Burgalassi, S., & Giannaccini, B. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90193-2 · Cited by 151
Liposome ocular delivery systems
Meisner, D., & Mezei, M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00016-z · Cited by 150
In Situ -Forming Gels for Ophthalmic Drug Delivery
Kumar, S., Häglund, B. O., & Himmelstein, K. J. (1994) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1994.10.47 · Cited by 143
Saettone, M. F., Chetoni, P., Cerbai, R., Mazzanti, G., & Braghiroli, L. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04663-7 · Cited by 129
Bioadhesive and phase-change polymers for ocular drug delivery
Robinson, J. R., & Mlynek, G. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00013-w · Cited by 124
Idoxuridine-Liposome Therapy for Herpes Simplex Keratitis
Smolin, G., Okumoto, M., Feiler, S., & Condon, D. (1981) · American Journal of Ophthalmology · doi:10.1016/0002-9394(81)90177-x · Cited by 119
Absorption enhancers in nasal drug delivery: efficacy and safety
Merkus, F. W. H. M., Schipper, N. G. M., Hermens, W. A. J. J., Romeijn, S. G., & Verhoef, J. C. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90179-9 · Cited by 117
Preparation and evaluation of acetazolamide liposomes as an ocular delivery system
El-Gazayerly, O. N., & Hikal, A. H. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00186-5 · Cited by 113
Poly(ε-Caprolactone) Nanocapsules in Carteolol Ophthalmic Delivery
Marchal‐Heussler, L., Sirbat, D., Hoffman, M., & Maincent, P. (1993) · Pharmaceutical Research · doi:10.1023/a:1018936205485 · Cited by 110
Calvo, P., THOMAS, C., Alonso, M. J., Vila-Jato, J. L., & Robinson, J. R. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90179-1 · Cited by 91
Fiber matrix model of sclera and corneal stroma for drug delivery to the eye
Edwards, A., & Prausnitz, M. R. (1998) · AIChE Journal · doi:10.1002/aic.690440123 · Cited by 89
Ocular drug delivery of progesterone using nanoparticles
Li, V. H. K., Wood, R. W., Kreuter, J., Harmia, T., & Robinson, J. R. (1986) · Journal of Microencapsulation · doi:10.3109/02652048609031575 · Cited by 83
Ocular drug bioavailability from topically applied liposomes
Lee, V. H. L., Urrea, P. T., Smith, R. E., & Schanzlin, D. J. (1985) · Survey of Ophthalmology · doi:10.1016/0039-6257(85)90109-2 · Cited by 81
Fitzgerald, P. B., Hadgraft, J., Kreuter, J., & WILSON, C. G. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90050-0 · Cited by 80
Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use
Edsman, K. L. M., Carlfors, J., & Harju, K. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04525-5 · Cited by 78
Systemic absorption of ocular pilocarpine is modified by polymer matrices
Urtti, A. O. (1985) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(85)90005-5 · Cited by 76
Bochot, A., Fattal, E., Grossiord, J., Puisieux, F., & Couvreur, P. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00419-5 · Cited by 75
Rheological evaluation of deacetylated gellan gum (Gelrite) for pharmaceutical use
Deasy, P. B., & Quigley, K. J. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90034-l · Cited by 73
Biomaterials in ophthalmic drug delivery
Sintzel, M. B., Bernatchez, S. F., Tabatabay, C., & Gurny, R. (1996) · Archive ouverte UNIGE (University of Geneva) · Cited by 73
Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits
Kunou, N., Ogura, Y., Hashizoe, M., Honda, Y., Hyon, S., & Ikada, Y. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00074-i · Cited by 71
Marshall, W. S., & Klyce, D. (1983) · The Journal of Membrane Biology · doi:10.1007/bf01870542 · Cited by 69
Prolongation of Corneal Allograft Survival with Liposome-encapsulated Cyclosporine in the Rat Eye
Milani, J. K., Pleyer, U., Dukes, A. J., et al. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31558-7 · Cited by 65
Collagen-Based Drug Delivery and Artificial Tears
Kaufman, H. E., Steinemann, T. L., LEHMAN, E., et al. (1994) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1994.10.17 · Cited by 64
Reer, O., Bock, T. K., & Müller, B. W. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830928 · Cited by 60
Controlled Ocular Timolol Delivery: Systemic Absorption and Intraocular Pressure Effects in Humans
Urtti, A. O., Rouhiainen, H. J., Kaila, T. J., & Saano, V. (1994) · Pharmaceutical Research · doi:10.1023/a:1018938310628 · Cited by 57
Meseguer, G., Gurny, R., & Buri, P. A. (1994) · Journal of drug targeting · doi:10.3109/10611869409015908 · Cited by 55
Microparticulates for Ophthalmic Drug Delivery
Joshi, A. (1994) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1994.10.29 · Cited by 55
Biodegradable Poly(Lactic Acid) and Poly (Lactide-Co-Glycolide) Polymers in Sustained Drug Delivery
Jalil, R. (1990) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049009058535 · Cited by 52
Liaw, J., & Robinson, J. R. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90309-p · Cited by 51
A new vitreal drug delivery system using an implantable biodegradable polymeric device.
Kimura, H., Ogura, Y., Hashizoe, M., Nishiwaki, H., Honda, Y., & Ikada, Y. (1994) · PubMed · Cited by 50
Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
Kyyrönen, K., & Urtti, A. O. (1990) · PubMed · Cited by 49
2-hydroxypropyl-β-cyclodextrin in topical carbonic anhydrase inhibitor formulations
Loftsson, Þ., Friđriksdóttir, H., Thórisdóttir, S., Stefánsson, E., Sigurðardóttir, A. M., Gudmundsson, Ó. S., & Sigthórsson, T. (1994) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(94)90001-9 · Cited by 49
Ophthalmic Preservatives as Absorption Promoters for Ocular Drug Delivery
Sasaki, H., Nagano, T., Yamamura, K., Nishida, K., & Nakamura, J. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb06726.x · Cited by 48
Mechanisms and facilitation of corneal drug penetration
Lee, V. H. L. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90122-a · Cited by 47
Bernatchez, S. F., Merkli, A., Minh, T. L., Tabatabay, C., Anderson, J. M., & Gurny, R. (1994) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820280908 · Cited by 37
A preliminary study of corneal penetration of125l‐labelled idoxuridine liposome
Dharma, S. K., Fishman, P. H., & Peyman, G. A. (1986) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.1986.tb06923.x · Cited by 31
Penetration of β-Blockers through Ocular Membranes in A1bino Rabbits
Sasaki, H., Igarashi, Y., Nagano, T., Yamamura, K., Nishida, K., & Nakamura, J. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb05726.x · Cited by 31
Davies, I. B., Rg, B., Sever, P. S., et al. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb04616.x · Cited by 29
In-vivostudies on dexamethasone sodium phosphate liposomes
Al-Muhammed, J., Özer, A. Y., ERCAN, M. T., et al. (1996) · Journal of Microencapsulation · doi:10.3109/02652049609026017 · Cited by 28
Controlled Delivery of Pilocarpine. 1. In Vitro Characterization of Gelfoam® Matrices
Nadkarni, S. R., & Yalkowsky, S. H. (1993) · Pharmaceutical Research · doi:10.1023/a:1018985332376 · Cited by 24
The influence of penetration enhancers on the volume instilled of eye drops
Santvliet, L. V., & Ludwig, A. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00114-8 · Cited by 24
Johansen, S., Prause, J. U., & Rask‐Pedersen, E. (1996) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1996.tb00087.x · Cited by 13
Grammer, J. B., Kortüm, F. A., Wolburg, H., et al. (1996) · Current Eye Research · doi:10.3109/02713689609017622 · Cited by 12
Drug release profiles of ophthalmic formulations. 1. Instrumentation
Stevens, L. E., Missel, P. J., & Lang, J. C. (1992) · Analytical Chemistry · doi:10.1021/ac00031a005 · Cited by 7
Cited by
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Marsac, P. J., Li, T., & Taylor, L. S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9721-1 · Cited by 507
Mandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.012 · Cited by 481
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A., Singla, A. K., & Aggarwal, D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
Ocular drug delivery: present innovations and future challenges
Gote, V., Sikder, S., Sicotte, J., & Pal, D. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256933 · Cited by 441
Metadata
- Authors
- Pal Kaur, I., & Kanwar, M.
- Venue
- Drug Development and Industrial Pharmacy
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 28
- Issue
- 5
- Pages
- 473-493
- ISSN
- 0363-9045 (ISSN-L)
- 1520-5762
- OpenAlex
- W2115305419
- Cited by
- 310
- References
- 73
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.